Stine E. Nielsen

1.1k total citations
16 papers, 903 citations indexed

About

Stine E. Nielsen is a scholar working on Nephrology, Ophthalmology and Pathology and Forensic Medicine. According to data from OpenAlex, Stine E. Nielsen has authored 16 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 4 papers in Ophthalmology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Stine E. Nielsen's work include Chronic Kidney Disease and Diabetes (7 papers), Acute Kidney Injury Research (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Stine E. Nielsen is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Acute Kidney Injury Research (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Stine E. Nielsen collaborates with scholars based in Denmark, Germany and United Kingdom. Stine E. Nielsen's co-authors include Peter Rossing, Hans‐Henrik Parving, Peter Hovind, Frederik Persson, Dietmar Zdunek, Takeshi Sugaya, Georg Heß, K. J. Schjoedt, Tsuneharu Baba and Richard J. MacIsaac and has published in prestigious journals such as Diabetes Care, Diabetes and Kidney International.

In The Last Decade

Stine E. Nielsen

16 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stine E. Nielsen Denmark	12	494	204	150	134	113	16	903
Marta Lapsley United Kingdom	18	362 0.7×	49 0.2×	291 1.9×	62 0.5×	35 0.3×	26	1.1k
Georg Jaremko Sweden	20	341 0.7×	265 1.3×	180 1.2×	70 0.5×	8 0.1×	40	1.1k
Alison Skene Australia	10	304 0.6×	103 0.5×	118 0.8×	54 0.4×	8 0.1×	19	925
Lysette N. Broekhuizen Netherlands	9	149 0.3×	65 0.3×	76 0.5×	19 0.1×	22 0.2×	16	756
Anja Mühlfeld Germany	15	213 0.4×	62 0.3×	147 1.0×	36 0.3×	6 0.1×	27	912
Julia Lepenies Germany	12	295 0.6×	172 0.8×	187 1.2×	20 0.1×	6 0.1×	16	754
Hyun Hee Lee South Korea	15	165 0.3×	50 0.2×	243 1.6×	58 0.4×	7 0.1×	43	603
Eli A. Friedman United States	10	119 0.2×	165 0.8×	65 0.4×	180 1.3×	7 0.1×	11	517
Kentaro Koike Japan	17	508 1.0×	45 0.2×	174 1.2×	13 0.1×	7 0.1×	69	866
Joseph L. Alge United States	10	460 0.9×	44 0.2×	113 0.8×	29 0.2×	4 0.0×	17	667

Countries citing papers authored by Stine E. Nielsen

Since Specialization

Citations

This map shows the geographic impact of Stine E. Nielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stine E. Nielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stine E. Nielsen more than expected).

Fields of papers citing papers by Stine E. Nielsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stine E. Nielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stine E. Nielsen. The network helps show where Stine E. Nielsen may publish in the future.

Co-authorship network of co-authors of Stine E. Nielsen

This figure shows the co-authorship network connecting the top 25 collaborators of Stine E. Nielsen. A scholar is included among the top collaborators of Stine E. Nielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stine E. Nielsen. Stine E. Nielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Nielsen, Stine E., et al.. (2025). One tube for all: 1‐year outcomes after transition to Paul glaucoma implant at a tertiary centre. Acta Ophthalmologica. 103(4). 461–468. 2 indexed citations

Nielsen, Stine E., Anders Ivarsen, & Jesper Hjortdal. (2019). Increasing incidence of Acanthamoeba keratitis in a large tertiary ophthalmology department from year 1994 to 2018. Acta Ophthalmologica. 98(5). 445–448. 26 indexed citations

Sturm, Dietrich, Jan Vollert, Andrew S.C. Rice, et al.. (2019). Implementation of a Quality Index for Improvement of Quantification of Corneal Nerves in Corneal Confocal Microscopy Images: A Multicenter Study. Cornea. 38(7). 921–926. 9 indexed citations

Nielsen, Stine E., Esben Nielsen, Jens Lindegaard, et al.. (2014). Incidence and clinical characteristics of fungal keratitis in a Danish population from 2000 to 2013. Acta Ophthalmologica. 93(1). 54–58. 79 indexed citations

Nielsen, Stine E., Frederik Persson, Erik Frandsen, et al.. (2012). Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo‐controlled crossover study. Diabetic Medicine. 29(8). e184–90. 69 indexed citations

Nielsen, Stine E., Kasper Rossing, Georg Heß, et al.. (2012). The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP. Scandinavian Journal of Clinical and Laboratory Investigation. 72(2). 137–142. 20 indexed citations

Nielsen, Stine E., Henrik Reinhard, Dietmar Zdunek, et al.. (2012). Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. Diabetes Research and Clinical Practice. 97(1). 71–76. 79 indexed citations

Theilade, Simone, Maria Lajer, Christel Joergensen, et al.. (2012). 67 FIRST EVER 24-HOUR CENTRAL BLOOD PRESSURE IN PATIENTS WITH TYPE 1 DIABETES. Journal of Hypertension. 30(Supplement 1). e21–e21. 1 indexed citations

Nielsen, Stine E., K. J. Schjoedt, Frederik Persson, et al.. (2012). Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney disease. Journal of the Renin-Angiotensin-Aldosterone System. 14(2). 161–166. 25 indexed citations

10.

Zürbig, Petra, George Jerums, Peter Hovind, et al.. (2012). Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy. Diabetes. 61(12). 3304–3313. 209 indexed citations

11.

Nielsen, Stine E., Steen Andersen, Dietmar Zdunek, et al.. (2011). Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney International. 79(10). 1113–1118. 82 indexed citations

12.

Nielsen, Stine E., K. J. Schjoedt, Anne Sofie Astrup, et al.. (2010). Neutrophil Gelatinase‐Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross‐sectional study and the effects of lisinopril. Diabetic Medicine. 27(10). 1144–1150. 119 indexed citations

13.

Nielsen, Stine E., Takeshi Sugaya, Peter Hovind, et al.. (2010). Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients. Diabetes Care. 33(6). 1320–1324. 96 indexed citations

14.

Nielsen, Stine E., Takeshi Sugaya, Peter Hovind, et al.. (2010). Urinary liver-type fatty acid-binding protein (u-LFABP) predicts progression to nephropathy in type 1 diabetic patients. Running title: The tubular marker u-LFABP in type 1 diabetes. 3 indexed citations

15.

Nielsen, Stine E., Henrik Post Hansen, Berit R. Jensen, Hans‐Henrik Parving, & Peter Rossing. (2010). Urinary Neutrophil Gelatinase-Associated Lipocalin and Progression of Diabetic Nephropathy in Type 1 Diabetic Patients in a Four-Year Follow-Up Study. Nephron Clinical Practice. 118(2). c130–c135. 18 indexed citations

16.

Nielsen, Stine E., Takeshi Sugaya, Lise Tarnow, et al.. (2009). Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition. Diabetes Care. 32(9). 1684–1688. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact